AIC
LFMD icon

Archer Investment Corporation’s LifeMD LFMD Stock Holding History

Archer Investment Corporation’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-55
Closed -$373 – 1201
2025
Q3 		$373 Hold
55
– – ﹤0.01% 1118
2025
Q2 		$749 Buy
+55
New +$519 ﹤0.01% 1054

Other funds holding LFMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Archer Investment Corporation's LFMD Position: Q4 2025 in Review

Archer Investment Corporation sold out of LifeMD (LFMD) in Q4 2025, closing a stake of 55 shares — an estimated $373 sold.

Archer Investment Corporation first reported a position in LFMD in Q2 2025 and held it in 2 quarters. The position peaked at $749 in Q2 2025. 104 funds tracked by Wall St. Rank hold LFMD as of Q4 2025.

  • Archer Investment Corporation reported no remaining LifeMD position as of Q4 2025 after selling out during the quarter.
  • Archer Investment Corporation sold 55 LifeMD shares in Q4 2025, an estimated $373.
  • Archer Investment Corporation first reported a position in LifeMD in Q2 2025 and held it in 2 quarters.
  • Archer Investment Corporation's LifeMD position peaked at $749 in Q2 2025.
  • 104 funds tracked by Wall St. Rank held LifeMD as of Q4 2025.

Based on Archer Investment Corporation's 13F filing for Q4 2025, filed 30 Jan 2026.